Literature DB >> 16876402

Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.

David C Tully1, Hong Liu, Arnab K Chatterjee, Phil B Alper, Robert Epple, Jennifer A Williams, Michael J Roberts, David H Woodmansee, Brian T Masick, Christine Tumanut, Jun Li, Glen Spraggon, Michael Hornsby, Jonathan Chang, Tove Tuntland, Thomas Hollenbeck, Perry Gordon, Jennifer L Harris, Donald S Karanewsky.   

Abstract

The synthesis and structure-activity relationship of a series of arylaminoethyl amide cathepsin S inhibitors are reported. Optimization of P3 and P2 groups to improve overall physicochemical properties resulted in significant improvements in oral bioavailability over early lead compounds. An X-ray structure of compound 37 bound to the active site of cathepsin S is also reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876402     DOI: 10.1016/j.bmcl.2006.07.033

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Design, synthesis and biological evaluation of a library of thiocarbazates and their activity as cysteine protease inhibitors.

Authors:  Zhuqing Liu; Michael C Myers; Parag P Shah; Mary Pat Beavers; Phillip A Benedetti; Scott L Diamond; Amos B Smith; Donna M Huryn
Journal:  Comb Chem High Throughput Screen       Date:  2010-05       Impact factor: 1.339

Review 2.  Zinc-binding cysteines: diverse functions and structural motifs.

Authors:  Nicholas J Pace; Eranthie Weerapana
Journal:  Biomolecules       Date:  2014-04-17

3.  Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies.

Authors:  Hanan S Anbar; Mohammed I El-Gamal; Hamadeh Tarazi; Bong S Lee; Hong R Jeon; Dow Kwon; Chang-Hyun Oh
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.